THE WILSDEN MEDICAL PRACTICE
2 LINGBOB COURT, WILSDEN, BRADFORD
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 16 | 19 | 84.2% | |
| HF 4 | 2011 | 17 | 23 | 73.9% | |
| HF 4 | 2012 | 24 | 28 | 85.7% | |
| HF 4 | 2013 | 24 | 29 | 82.8% | |
| HF004 | 2014 | 11 | 12 | 91.7% | |
| HF004 | 2015 | 16 | 16 | 100.0% | |
| HF004 | 2016 | 11 | 11 | 100.0% | |
| HF004 | 2017 | 16 | 16 | 100.0% | |
| HF004 | 2018 | 19 | 22 | 86.4% | |
| HF004 | 2019 | 32 | 36 | 88.9% | |
| HF004 | 2020 | 31 | 33 | 93.9% | |
| HF006 | 2021 | 36 | 39 | 92.3% | |
| HF006 | 2022 | 45 | 45 | 100.0% | |
| HF006 | 2023 | 50 | 52 | 96.2% |
